{
    "nct_id": "NCT03674138",
    "official_title": "Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients",
    "inclusion_criteria": "* Patients with a cancer diagnosis\n* Be 18 years of age or older\n* Patients who rate depression or anxiety > 5 based on a 10 point scale\n* Patients expected to live greater than 6 months\n* Serum bilirubin and creatinine < 1.5x upper limit of normal\n* AST and ALT < 3 times upper limit of normal\n* Willing and able to provide written informed consent\n* Able to complete self-assessment questionnaires\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients not diagnosed with cancer\n* Antidepressant prescribing performed by a non-Moffitt psychiatrist after enrollment onto the clinical trial\n* Known Pregnancy\n* History of liver or allogenic stem cell transplant\n* Patients with a known cognitive impairment (e.g., delirium, dementia, etc.) or psychological impairment (e.g., schizophrenia, bipolar disease, etc.) other than depressive and anxiety symptoms.",
    "miscellaneous_criteria": ""
}